TransMedics Group Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 14, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,072	4,157	2,093	2,577	1,970	532
Market Cap Growth	-31.76%	98.67%	-18.80%	30.78%	270.34%	-1.57%
Enterprise Value	3,467	4,210	2,281	2,665	1,834	464
Last Close Price	88.58	121.65	62.35	78.93	61.72	19.16
PE Ratio	22.07	21.85	59.01	-	-	-
Forward PE	47.49	47.40	56.70	-	-	-
PS Ratio	4.59	6.87	4.74	10.67	21.08	17.58
PB Ratio	5.92	8.79	9.15	18.78	10.52	7.84
P/TBV Ratio	6.06	9.05	9.74	20.97	10.52	7.84
P/FCF Ratio	38.86	31.12	-	-	-	-
P/OCF Ratio	21.05	21.56	42.88	-	-	-
PEG Ratio	-	0.93	-	-	-	-
EV/Sales Ratio	5.19	6.95	5.17	11.03	19.62	15.34
EV/EBITDA Ratio	29.98	31.31	39.83	400.09	-	-
EV/EBIT Ratio	42.48	38.78	60.82	-	-	-
EV/FCF Ratio	43.86	31.52	-	-	-	-
Debt / Equity Ratio	1.68	1.10	2.27	3.76	0.36	0.65
Debt / EBITDA Ratio	6.99	3.65	8.19	45.04	-	-
Debt / FCF Ratio	10.98	3.89	-	-	-	-
Net Debt / Equity Ratio	0.76	0.07	0.80	0.88	-0.71	-0.72
Net Debt / EBITDA Ratio	3.42	0.23	3.17	18.18	4.78	1.29
Net Debt / FCF Ratio	5.00	0.23	-2.24	-0.73	2.32	1.50
Asset Turnover	0.57	0.65	0.59	0.49	0.45	0.21
Inventory Turnover	5.46	5.09	3.95	2.70	1.59	0.68
Quick Ratio	5.87	6.41	7.25	8.34	9.67	4.23
Current Ratio	6.63	7.14	8.30	9.30	10.66	5.11
Return on Equity (ROE)	36.29%	54.24%	19.39%	-15.42%	-28.39%	-51.49%
Return on Assets (ROA)	4.33%	7.25%	3.10%	-0.19%	-9.54%	-17.18%
Return on Invested Capital (ROIC)	9.02%	23.75%	11.12%	-0.97%	-86.19%	-245.59%
Return on Capital Employed (ROCE)	6.00%	11.10%	5.00%	-0.20%	-12.40%	-35.30%
Earnings Yield	4.94%	4.58%	1.70%	-0.97%	-1.84%	-8.31%
FCF Yield	2.57%	3.21%	-3.87%	-6.40%	-2.93%	-6.09%
Buyback Yield / Dilution	-1.53%	-15.12%	-8.30%	-10.02%	-7.02%	-11.80%

SEC Filings: 10-K · 10-Q